Drug-testing on seropositive pregnant women in the developing world: moral and legal implications.
Mayss
A
A
Law School, University of Liverpool, UK.
D015492:AIDS Serodiagnosis / Q000941:ethics; D001942:Breast Feeding; D002986:Clinical Trials as Topic / Q000941:ethics* / Q000331:legislation & jurisprudence; D035881:Compensation and Redress; D003219:Confidentiality; D032962:Consent Forms; D003376:Counseling; D003906:Developing Countries; D030881:Disclosure / Q000941:ethics; D015507:Drugs, Investigational / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D005260:Female; D017408:Guidelines as Topic; D015658:HIV Infections / Q000188:drug therapy; D006679:HIV Seropositivity; D006297:Health Services Accessibility / Q000941:ethics; D006805:Human Experimentation / Q000592:standards; D006806:Human Rights; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D007258:Informed Consent; D038622:Internationality; D009035:Mothers; D026684:Personal Autonomy; D011247:Pregnancy; D037841:Pregnant People; D035842:Research Subjects; D012935:Social Justice; D015215:Zidovudine / Q000627:therapeutic use
D015507:Drugs, Investigational; D015215:Zidovudine